Jenny Lynna' Gibbs Hall, AG-ANCP-BC Nurse Practitioner - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 704 Pinnacle Hill Rd, Kingston Springs, TN 37082 Phone: 615-945-8890 Fax: 615-952-4870 |
Cynthia Borum, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 448 Harpeth Meadows Dr, Kingston Springs, TN 37082 Phone: 615-945-9401 |
Katherine Lankford, Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1064 Founders Ln, Kingston Springs, TN 37082 Phone: 615-516-3524 |
News Archive
In a study published in Brain Research, biophysicists from the Institute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences and MIPT have shown that drug-induced activation of the endocannabinoid system of the brain leads to reduced or completely suppressed epileptic activity in test animals.
Promising results from Phase II clinical trials and important biological advances in diagnosis and prognosis will be presented here, at the conference on Molecular Origins of Lung Cancer from Jan. 11-14, 2010. This conference is jointly sponsored by the AACR and the International Association for the Study of Lung Cancer.
Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.
Remember that sound bite you heard on the radio this morning? The grocery items your spouse asked you to pick up? Chances are, you won't.
An international team of researchers led by the University of British Columbia has made a scientific advance they hope will lead to the development of preventative treatments for multiple sclerosis.
› Verified 9 days ago